Evidence map›Paper›PMID 18420501›Full record

ReviewThe New England journal of medicine2008

Clinical practice. Irritable bowel syndrome.

Emeran A Mayer

2 registry-linked trialsAbstract readReview
In one paragraph

Review in The New England journal of medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02651532 completednot on this mapstarted 2016, after this paper: background citation

Confocal Endomicroscopy Utility for Diagnosing Mucosa Micro-inflammation in Patients With Irritable Bowel Syndrome

TypeobservationalSponsorInstituto Ecuatoriano de Enfermedades DigestivasRan2016 to 2017Enrolled74ConditionsIrritable Bowel Syndrome (IBS)ArmsConfocal Laser Endomicroscopy
NCT06420843 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Microbiota, Metabolome and Nutrition: an 'Artificially Intelligent' Way to Personalized Nutrition

TypeinterventionalSponsorIstituto Clinico HumanitasRan2021 to 2024Enrolled48ConditionsIBS - Irritable Bowel SyndromeArmsFOODMAP
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2010
    Trial
  13. Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
    Trial
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Sex as a biological variable in irritable bowel syndrome.Neurogastroenterology and motility · 2020
    Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emeran A MayerCenter for Neurobiology of Stress, Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6949, USA. emayer@ucla.edu

Funding

Women's Health and Functional Visceral Disorders CenterP50DK064539 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2002 to 2017
$17.5M
PERCEPTION AND MODULATION OF VISCERAL SENSATIONSR01DK048351 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 1996 to 2019
$8.2M
Mind/Brain/Body Interactions in Stress-Related DisordersR24AT002681 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2004 to 2008
$4.6M
Peripheral NMDA Receptors in Visceral NociceptionR01DK058173 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCROBERTS, JAMES A · 2001 to 2009
$2.3M
NCCIH NIH HHS R24 AT002681NIDDK NIH HHS P50 DK064539NIDDK NIH HHS P50 DK64539NIDDK NIH HHS R01 DK048351NIDDK NIH HHS R01 DK058173NIDDK NIH HHS R01 DK48351NIDDK NIH HHS R01 DK58173
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cognitive Behavioral TherapyAdultAntidepressive Agents, TricyclicCarbolinesDesipramineFemaleGastrointestinal AgentsHumansIndolesIrritable Bowel SyndromeMaleParasympatholyticsPractice Guidelines as TopicalosetronAntidepressive Agents, TricyclicCarbolinesDesipramineGastrointestinal AgentsIndolesParasympatholyticstegaserod

Identifiers

PMID18420501
PMCPMC3816529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.